These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 974021)

  • 1. Adverse reaction to the beta-adrenergic blocking drugs.
    Brigden WD; Almeyda J
    Br J Dermatol; 1976 Sep; 95(3):335-8. PubMed ID: 974021
    [No Abstract]   [Full Text] [Related]  

  • 2. Problems with practolol.
    Wall-Manning HJ
    Drugs; 1975; 10(5-6):336-41. PubMed ID: 1240
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological changes and practolol.
    Amos HE; Brigden WD
    Lancet; 1976 Dec; 2(7998):1298. PubMed ID: 63765
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse reactions to practolol: some observations on the possible relevence to immune mechanisms.
    Dick HM; Wright P; Chapman CM; Zacharias FJ; Nicholls JT
    Allergy; 1978 Apr; 33(2):71-5. PubMed ID: 80139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Untoward effects associated with practolol administration: oculomucocutaneous syndrome.
    Wright P
    Br Med J; 1975 Mar; 1(5958):595-8. PubMed ID: 1125623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eye and skin reactions precede practolol peritonitis.
    Idänpään-Heikkilä JE; Hästbacka J; Järvinen HJ
    Lancet; 1977 Dec 24-31; 2(8052-8053):1354. PubMed ID: 74720
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fibrinous peritonitis and ocular reactions: a complication of practolol therapy (author's transl)].
    Kestens PJ; Muschart JM; Koerperich G; Aubry E
    Acta Gastroenterol Belg; 1977; 40(3-4):175-87. PubMed ID: 899618
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sclerosing peritonitis and practolol (author's transl)].
    Hess T; Stucki P
    Med Klin; 1977 Jul; 72(28-29):1220-4. PubMed ID: 887049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An instructive example of a long-latency adverse drug reaction--sclerosing peritonitis due to practolol.
    Mann RD
    Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1211-6. PubMed ID: 17853493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Letter: Skin reactions due to practolol].
    Marghescu S
    Hautarzt; 1975 Dec; 26(12):663. PubMed ID: 1213887
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Report on adverse reactions associated with practolol.
    Proctor CR
    Med J Aust; 1974 Nov; 2(20):758. PubMed ID: 4280498
    [No Abstract]   [Full Text] [Related]  

  • 12. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol).
    Brown P; Baddeley H; Read AE; Davies JD; McGarry J
    Lancet; 1974 Dec; 2(7895):1477-81. PubMed ID: 4140395
    [No Abstract]   [Full Text] [Related]  

  • 13. Practolol-induced autoantibodies and their relation to oculo-cutaneous complications.
    Jachuck SJ; Stephenson J; Bird T; Jackson FS; Clark F
    Postgrad Med J; 1977 Feb; 53(616):75-7. PubMed ID: 141660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [From The committee for the Registration of Adverse Effects. Adverse effects following Eraldin therapy].
    Lunde I; Borchgrevink CF
    Tidsskr Nor Laegeforen; 1975 Oct; 95(28):1609. PubMed ID: 1179394
    [No Abstract]   [Full Text] [Related]  

  • 15. Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome.
    Amos HE; Lake BG; Artis J
    Br Med J; 1978 Feb; 1(6110):402-4. PubMed ID: 146533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.
    Frishman W; Silverman R; Strom J; Elkayam U; Sonnenblick E
    Am Heart J; 1979 Aug; 98(2):256-62. PubMed ID: 36744
    [No Abstract]   [Full Text] [Related]  

  • 17. Practolol peritonitis. A study of 16 cases and a survey of small bowel function in patients taking beta adrenergic blockers.
    Marshall AJ; Baddeley H; Barritt DW; Davies JD; Lee RE; Low-Beer TS; Read AE
    Q J Med; 1977 Jan; 46(181):135-49. PubMed ID: 866567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practolol and the nephrotic syndrome.
    Farr MJ; Wingate JP; Shaw JN
    Br Med J; 1975 Apr; 2(5962):68-9. PubMed ID: 1131550
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions.
    Kendall MJ; Beeley L
    Pharmacol Ther; 1983; 21(3):351-69. PubMed ID: 6138787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy.
    Behan PO; Behan WM; Zacharias FJ; Nicholls JT
    Lancet; 1976 Nov; 2(7993):984-7. PubMed ID: 62263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.